DEXCOM, INC. Cash and Cash Equivalents, Period Increase (Decrease)
DEXCOM, INC. (DXCM) reported Cash and Cash Equivalents, Period Increase (Decrease) of $347.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-02-27
- DEXCOM, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $39.40M.
- DEXCOM, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $6.20M, a 39.22% decline year-over-year.
- DEXCOM, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was $242.40M, a 2425.00% increase year-over-year.
- DEXCOM, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $59.00M.
- DEXCOM, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $347.00M, a 4030.95% increase from fiscal 2016.
- DEXCOM, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $8.40M, a 41.26% decline from fiscal 2015.
- DEXCOM, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $14.30M, a 50.00% decline from fiscal 2014.
- DEXCOM, INC. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $28.60M, a 18.52% decline from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $39.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $45.60M derived: sum of 2 quarters · filed 2018-02-27 | $288.00M derived: sum of 3 quarters · filed 2018-02-27 | $347.00M 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | $6.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $248.60M derived: sum of 2 quarters · filed 2017-11-01 | $307.60M 10-Q · filed 2017-11-01 | $304.40M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2017-06-30 | $242.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $301.40M 10-Q · filed 2017-08-01 | $298.20M derived: sum of 3 quarters · filed 2018-02-27 | $308.40M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2017-03-31 | $59.00M 10-Q · filed 2017-05-02 | $55.80M derived: sum of 2 quarters · filed 2018-02-27 | $66.00M derived: sum of 3 quarters · filed 2018-02-27 | $75.60M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-12-31 | -$3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $7.00M derived: sum of 2 quarters · filed 2018-02-27 | $16.60M derived: sum of 3 quarters · filed 2018-02-27 | $8.40M 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $10.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $19.80M derived: sum of 2 quarters · filed 2017-11-01 | $11.60M 10-Q · filed 2017-11-01 | $12.40M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $9.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $1.40M 10-Q · filed 2017-08-01 | $2.20M derived: sum of 3 quarters · filed 2018-02-27 | $19.80M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | -$8.20M 10-Q · filed 2017-05-02 | -$7.40M derived: sum of 2 quarters · filed 2018-02-27 | $10.20M derived: sum of 3 quarters · filed 2018-02-27 | $23.70M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $18.40M derived: sum of 2 quarters · filed 2018-02-27 | $31.90M derived: sum of 3 quarters · filed 2018-02-27 | $14.30M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $17.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $31.10M derived: sum of 2 quarters · filed 2016-11-01 | $13.50M 10-Q · filed 2016-11-01 | $22.10M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $13.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | -$4.10M 10-Q · filed 2016-08-02 | $4.50M derived: sum of 3 quarters · filed 2017-02-28 | $18.20M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | -$17.60M 10-Q · filed 2016-04-27 | -$9.00M derived: sum of 2 quarters · filed 2017-02-28 | $4.70M derived: sum of 3 quarters · filed 2017-02-28 | $8.50M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $22.30M derived: sum of 2 quarters · filed 2017-02-28 | $26.10M derived: sum of 3 quarters · filed 2017-02-28 | $28.60M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $13.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $17.50M derived: sum of 2 quarters · filed 2015-11-04 | $20.00M 10-Q · filed 2015-11-04 | $29.80M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | $3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $6.30M 10-Q · filed 2015-08-05 | $16.10M derived: sum of 3 quarters · filed 2016-02-23 | $21.30M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | $2.50M 10-Q · filed 2015-04-29 | $12.30M derived: sum of 2 quarters · filed 2016-02-23 | $17.50M derived: sum of 3 quarters · filed 2016-02-23 | $26.80M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2013-12-31 | $9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $15.00M derived: sum of 2 quarters · filed 2016-02-23 | $24.30M derived: sum of 3 quarters · filed 2016-02-23 | $35.10M 10-K · filed 2016-02-23 | ||||
| 2013-09-30 | $5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $14.50M derived: sum of 2 quarters · filed 2014-11-06 | $25.30M 10-Q · filed 2014-11-06 | $28.60M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $9.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $20.10M 10-Q · filed 2014-08-06 | $23.40M derived: sum of 3 quarters · filed 2015-02-25 | $22.20M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $10.80M 10-Q · filed 2014-05-01 | $14.10M derived: sum of 2 quarters · filed 2015-02-25 | $12.90M derived: sum of 3 quarters · filed 2015-02-25 | $13.70M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $2.10M derived: sum of 2 quarters · filed 2015-02-25 | $2.90M derived: sum of 3 quarters · filed 2015-02-25 | $5.50M 10-K · filed 2015-02-25 | ||||
| 2012-09-30 | -$1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | -$400.00K derived: sum of 2 quarters · filed 2013-11-06 | $2.20M 10-Q · filed 2013-11-06 | $2.19M 10-Q · filed 2012-11-01 | -$12.73M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2012-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $3.40M 10-Q · filed 2013-08-07 | $3.43M 10-Q · filed 2012-08-06 | -$11.53M derived: sum of 3 quarters · filed 2014-02-20 | -$27.90M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2012-03-31 | $2.60M 10-Q · filed 2013-05-01 | $2.57M 10-Q · filed 2012-05-02 | -$12.33M derived: sum of 2 quarters · filed 2014-02-20 | -$28.70M derived: sum of 3 quarters · filed 2014-02-20 | $1.38M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2011-12-31 | -$14.93M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | -$31.30M derived: sum of 2 quarters · filed 2014-02-20 | -$1.22M derived: sum of 3 quarters · filed 2014-02-20 | -$2.30M 10-K · filed 2014-02-20 | -$2.34M 10-K · filed 2012-02-23 | |||
| 2011-09-30 | -$16.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $13.72M derived: sum of 2 quarters · filed 2012-11-01 | $12.63M 10-Q · filed 2012-11-01 | $11.98M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $30.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $29.00M 10-Q · filed 2012-08-06 | $28.35M derived: sum of 3 quarters · filed 2013-02-21 | $27.79M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | -$1.08M 10-Q · filed 2012-05-02 | -$1.74M derived: sum of 2 quarters · filed 2013-02-21 | -$2.30M derived: sum of 3 quarters · filed 2013-02-21 | |||||
| 2010-12-31 | -$652.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | -$1.21M derived: sum of 2 quarters · filed 2013-02-21 | $1.30M 10-K · filed 2013-02-21 | $1.31M 10-K · filed 2012-02-23 | ||||
| 2010-09-30 | -$561.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $1.95M 10-Q · filed 2011-11-02 | ||||||
| 2010-06-30 | $2.51M 10-Q · filed 2011-08-03 | |||||||
| 2009-12-31 | -$9.12M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |